WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
WhiteLab Genomics is active in the healthcare space based in Paris, Île-de-France, France; Boston, MA, USA, founded in 2019.
Profile
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
The company sits in the healthcare segment, where it competes on its core product or service.
The business is associated with Paris, Île-de-France, France; Boston, MA, USA.
It is recorded at the Winter 2022 stage.
The company reports a headcount in the 40 range.
Public records show total funding of about $10.5M.
| Sector | Healthcare |
|---|---|
| Headquarters | Paris, Île-de-France, France; Boston, MA, USA |
| Country | USA |
| Founded | 2019 |
| Employees | 40 |
| Stage | Winter 2022 |
| Total funding | $10,500,000 |
Website: whitelabgx.com
Browse related
Sign in to view the contact information we hold for WhiteLab Genomics.
Create a free account
Create a free account